- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/58 - Amidines
Patent holdings for IPC class C07D 213/58
Total number of patents in this class: 35
10-year publication summary
|
4
|
1
|
2
|
4
|
1
|
1
|
1
|
0
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Neurocrine Biosciences, Inc. | 463 |
6 |
| Centre Regional de Lutte Contre le Cancer Francois Baclesse | 6 |
2 |
| Institut de Cancerologie de l'Ouest Rene Gauducheau | 3 |
2 |
| Oat Agrio Co., Ltd. | 45 |
2 |
| Purdue Pharma L.P. | 433 |
2 |
| Universite de Caen-basse Normandie | 38 |
2 |
| PI Industries Ltd | 203 |
2 |
| Epiodyne, Inc. | 7 |
2 |
| Bristol-myers Squibb Company | 4764 |
1 |
| Merck Patent GmbH | 5739 |
1 |
| Agency for Science, Technology and Research | 3753 |
1 |
| Duke University | 3186 |
1 |
| Northwestern University | 3564 |
1 |
| CHDI Foundation, Inc. | 107 |
1 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 128 |
1 |
| Flexus Biosciences, Inc. | 13 |
1 |
| ISP Investments Inc. | 441 |
1 |
| Karo Bio AB | 16 |
1 |
| Otsuka Agritechno Co., Ltd. | 2 |
1 |
| The Research Foundation for The State University of New York | 1758 |
1 |
| Other owners | 3 |